Abstract. The ether lipid 1-O-octadecyl-2-O-methyl-3-glycero-phosphocholine (ET-18-OMe) inhibits cell-cell adhesion and induces invasiveness of breast cancer cells. Previously, we showed that a loss of cell-cell adhesion was due to sterical hindrance of E-cadherin by the anti-adhesive properties of the cell surface mucin episialin. Here, we demonstrated that the ether lipid ET-18-OMe induced the translocation of E-cadherin and episialin to membrane microdomains, enriched in glycosphingolipids, known to be involved in cell-cell adhesion and cell signaling. In addition, it was found that E-cadherin and clusters of episialin colocalized and associated with the glycosphingolipid, MSGb5, upon treatment with ET-18-OMe. Together, these results suggest that ET-18-OMe inhibits cell-cell adhesion by inducing the translocation of E-cadherin and episialin into MSGb5-enriched membrane microdomains, which leads to clustering and colocalization of the pro-adhesive E-cadherin and the antiadhesive episialin thereby inhibiting cell-cell adhesion.
Introduction
The plasma membrane contains specialized membrane microdomains, enriched in glycosphingolipids (GSLs) (1) . Several studies suggested that these membrane microdomains play fundamental roles in numerous cellular functions by promoting segregated compartmentalization of membrane proteins and lipids (2) (3) (4) . In tumor cells, GSLs were identified as tumor-associated antigens (5) and function as mediators of cell adhesion and modulators of signal transduction, through differential organization, clustering and assembly with specific membrane proteins and signal transducers (4) .
The ether lipid 1-O-octadecyl-2-O-methyl-3-glycerophosphocholine (ET-18-OMe) is a selective antitumor agent, known to inhibit cancer cell proliferation (6) and to induce apoptosis (7) . The mechanism by which ET-18-OMe exerts the latter effect relates to its ability to interact with cell membranes, thereby reorganizing crucial molecules in membrane microdomains and interfering with subsequent signaling (8) . Previously, we showed that ET-18-OMe induced a loss of cell-cell adhesion and stimulated the invasion of MCF-7 breast cancer cells into collagen type I, which resulted in the inhibition of E-cadherin-mediated adhesion by episialin. Both E-cadherin and episialin, membrane-associated glycoproteins, were found to have colocalized in MCF-7 cells upon ET-18-OMe treatment (9) .
Given these previous observations, we investigated whether an ET-18-OMe-induced loss of cell-cell adhesion results from the reorganization and/or association of E-cadherin, episialin and glycosphingolipids in membrane microdomains.
Materials and methods
Cell culture. MCF-7/AZ and MCF-7/6 cells, variants of the human mammary carcinoma cell family MCF-7, were maintained on a tissue culture plastic substrate (Nunc, Rochester, NY) in a mixture of Dulbecco's modified Eagle's medium (DMEM) and HAM F12 (50/50) (Invitrogen, Carlsbad, CA) supplemented with 250 IU/ml penicillin, 100 mg/ml streptomycin and 10% fetal bovine serum (FBS) (Invitrogen), at 37˚C in a humidified atmosphere containing 10% CO 2 . MCF-7/AZ cells differ from MCF-7/6 cells in that they are not invasive when tested in precultured chick heart invasion in vitro (10) .
Reagents. ET-18-OMe (clinical grade) was provided by Dr P. Hilgard (ASTA Medica, Frankfurt am Main, Germany). E-cadherin and episialin in membrane microdomains and soluble fractions. Cells treated for 24 h with ET-18-OMe were used for the preparation of postnuclear fractions in 1% Triton X-100 followed by a sucrose gradient-density centrifugation to isolate 12 fractions, including membrane microdomains (fractions 4-6) and high-density soluble fractions (10-12) as described (14, 15) . Aliquots, containing the same quantity of proteins were boiled for 5 min in an SDS-PAGE sample buffer, containing 5% ß-mercaptoethanol, electrophoresed on 7.5% SDS-PAGE and transferred to PVDF membranes (Immobilon-P) (Bio-Rad Laboratories, Hercules, CA). After transfer, the membranes were incubated with the relevant antibodies, followed by incubation with a secondary biotinylated antibody (1:1000) and developed by the ECL (Vectastain ABC-AMP) detection kit. Membranes were imaged and analyzed on the BioChemi System and analysis software (UVP, Upland, CA).
Immunofluorescence detection of episialin, E-cadherin and
GSLs. Cells, grown on cover glasses and placed in 24-well plates, were treated for 24 h. Subsequently, the cover glasses with cells were removed, washed with ice-cold PBS and fixed with 3% paraformaldehyde. After washing, the fixed cells were incubated for 1 h with primary antibodies, against E-cadherin, episialin and glycosphingolipids, followed by incubation with secondary FITC-or TR-labeled antibodies. 
Immunoprecipitation of MSGb5 and the association with E-cadherin and episialin. Confluent cultures (70%) treated
for the indicated times with ET-18-OMe were lysed in 0.5 ml lysis buffer containing 1% Triton X-100, 1% NP-40 and the following inhibitors: aprotinin (10 μg/ml), leupeptin (10 μg/ ml), PMSF (1.72 mM), NaF (100 mM), NaVO 3 (500 μM) and Na 4 P 2 O 7 (500 μg/ml). Lysates, containing 2000 μg of protein, were mixed with protein G-Sepharose beads (Amersham Biosciences, NJ) (50 μl, packed) and placed on a rotator for 30 min at 4˚C, to preclear non-specific binding. After centrifugation at 1,000 rpm, to collect supernatant, 2 μl of IgG3 MSGb5 antibody was added and rotated at 4˚C overnight. Subsequently, protein G-Sepharose beads were added, rotated at 4˚C for 2 h and centrifuged to collect the beads. The beads were washed with lysis buffer and immunoprecipitates were resolved in 100 μl SDS-PAGE sample buffer and heated to 95˚C for 5 min. Supernatants were subjected to 7.5% SDS-PAGE, transferred electrophoretically to PVDF membranes, incubated with the relevant antibodies and analyzed and imaged as described above.
Statistics. All treatments were matched and carried out at least 3 times. The Student's t-test (95%, p<0.05) was used for statistical evaluation. Levels were quantified using the statistical software Scion image (Scion Corporation, MD).
Results

E-cadherin and episialin in membrane microdomains of MCF-7/AZ vs. MCF-7/6
cells. E-cadherin and episialin were associated with membrane microdomains [low density (fr. [4] [5] [6] and soluble high density fractions (10-12)] in both MCF-7/AZ and MCF-7/6 cells. Upon ET-18-OMe treatment, the levels of E-cadherin and episialin increased in fr. 4-6 and simultaneously decreased in fr. 10-12 in the MCF-7/AZ cells (Fig. 1, left  panel) , while no altered expression levels were observed in the MCF-7/6 cells ( Fig. 1, right panel) .
Localization and distribution patterns of E-cadherin and episialin and various GSLs in MCF-7/AZ vs. MCF-7/6 cells.
Localization and distribution patterns of E-cadherin and episialin and diverse GSLs in the membrane microdomains of MCF-7/AZ and MCF-7/6 cells were observed by confocal microscopy. The GSL composition of the two cell lines was previously determined by high-performance thin-layer chromatography (16, 17) . Fig. 2A shows the presence of E-cadherin at the lateral surface, whereas episialin was exclusively present at the apical surface in the two cell lines. Incubation of the MCF-7/AZ cells with ET-18-OMe led to the clustering and translocation of episialin to the lateral surface and colocalization with E-cadherin, in line with our previous study (9) (left panel), while no such effect was observed in the MCF-7/6 cells ( Fig. 2A, right panel ). An analysis of the localization of GSLs, upon ET-18-OMe treatment, revealed no major changes (data not shown) in the two cell lines except for MSGb5 in the MCF-7/AZ cells, which clustered and translocated to the lateral surface. In addition, upon treatment, both E-cadherin and episialin were found to have colocalized with MSGb5 patches in the MCF-7/AZ cells ( Fig. 2B and C, left panel) but not in the MCF-7/6 cells ( Fig. 2B and C, right panel).
Association of MSGb5 with E-cadherin and episialin. The association MSGb5 with E-cadherin and episialin was shown VAN SLAMBROUCK et al: COCLUSTERING OF E-CADHERIN AND EPISIALIN IN MEMBRANE MICRODOMAINS
by immunoprecipitation experiments. Both E-cadherin and episialin were detected in MSGb5 immunoprecipitates in MCF-7/AZ and MCF-7/6 cells. After treatment with ET-18-OMe increasing E-cadherin and episialin levels were found to be associated with MSGb5 in MCF-7/AZ cells ( Fig. 3A and B, left panel), while no differences in levels could be observed in MCF-7/6 cells ( Fig. 3A and B, right panel).
Discussion
The ether lipid, 1-O-octadecyl-2-O-methyl-3-glycerophosphocholine, is a synthetic analogue of 2-lysophosphatidylcholine and considered the prototype of the antitumor lipid class. Several studies revealed that the anticancer activity of ET-18-OMe is caused by the induction of apoptosis (7, 18) , through interaction with cell membranes (8, 19) . However, we found in a previous study that ET-18-OMe treatment induced a loss of E-cadherin-mediated cell-cell adhesion in MCF-7/AZ breast cancer cells (9) , representing a critical step in tumor cell invasion and metastasis (20) . Notably, the loss of cell-cell adhesion was not detected in the MCF-7/6 breast cancer cells and enabled us to identify differences responsible for the ET-18-OMe-induced effect. We showed that ET-18-OMe did not affect the cadherin-catenin complex but induced the loss of cell-cell adhesion due to the clustering and colocalization of E-cadherin and episialin in the plasma membrane which caused a sterical hindrance of E-cadherin by episialin. Antibodies against episialin restored the E-cadherin function as these antibodies removed episialin from the clustering (9). The reorganization and movement of specific membrane proteins were associated with membrane microdomains (3, 21) , enriched in glycosphingolipids, mediating cell-cell adhesion and modulating signal transduction (5) .
In the present study we examined whether the ET-18-OMe-induced effect on cell-cell adhesion in MCF-7/AZ breast cancer cells involved membrane microdomains. Our results showed that E-cadherin and episialin were associated with membrane microdomains in the two cell lines, which is in line with previous observations (17) . The ET-18-OMe treatment led to an increased inclusion of the two membrane proteins in these domains in MCF-7/AZ cells. Simultaneously, lower levels were found in soluble fractions, 10-12, of the MCF-7/AZ cells, whereas no differences were observed in the MCF-7/6 cells. Since ET-18-OMe treatment did not alter the expression levels of E-cadherin and episialin (9), these findings suggest that ET-18-OMe induces translocation of Ecadherin and episialin to the membrane microdomains in MCF-7/AZ cells. Such translocation was reported for Fas/ CD95 in human leukemic cells (7) .
In previous studies we reported the GSL composition of MCF-7/AZ and MCF-7/6 cells and demonstrated that ET-18-OMe treatment had no influence on the expression levels (16, 17) . Then, we examined changes in the cellular localization of E-cadherin and episialin and the possible connection with glycosphingolipids. Confocal microscopy revealed that ET-18-OMe treatment resulted in the translocation of episialin from the apical to the lateral side and clustering and colocalization with E-cadherin, which is consistent with our previous study ONCOLOGY REPORTS 19: 123-128, 2008 (9). In addition, ET-18-OMe caused clustering and translocation of the glycosphingolipid, MSGb5, to the lateral surface and colocalization with E-cadherin and episialin. We could exclude the involvement of several other GSLs present, since no significant changes in staining patterns were observed for the two cell lines. The obtained data indicated a close connection of E-cadherin and episialin with MSGb5 which was further confirmed by immunoprecipitation experiments, demonstrating the enhanced association of both E-cadherin and episialin with MSGb5 after ET-18-OMe treatment in MCF-7/AZ but not in MCF-7/6 cells. These results are in line with an increased inclusion of E-cadherin and episialin in membrane microdomain fractions in MCF-7/AZ cells (Fig. 1) . Furthermore, a recent report demonstrated that the association of cadherin complexes with membrane microdomains is required for their adhesive function (22) , which is in agreement with our previous study, where we showed that the cadherin complex remained intact upon ET-18-OMe treatment (9) . The latter, together with the present findings support that an ET-18-OMe-induced loss of cell-cell adhesion and stimulation of invasion are due to sterical hindrance of functional E-cadherin by episialin, through translocation, clustering and colocalization of E-cadherin and episialin with MSGb5 into MSGb5-enriched membrane microdomains. Few studies exist on MSGb5, however, all of them link MSGb5 to invasion and metastasis (16, 17, 23, 24) . Previous work showed that the stimulation of MSGb5, by its monoclonal antibody RM1, resulted in the clustering of MSGb5 with the subsequent activation of associated signaling molecules (17) leading to the enhanced secretion and activity of matrix metalloproteinases, which are known to stimulate invasion (16) .
In conclusion, the present study showed that ET-18-OMe alters cellular adhesion, through the translocation and reorganization of crucial molecules in membrane microdomains. It also highlights that the differential composition of membrane microdomains is important for understanding basic cellular activities and mechanisms. 
